Nephrotic syndrome
RecruitingStudy on Early Rituximab Treatment for Children with Nephrotic Syndrome
- Disease:Nephrotic syndrome
- Substances:Rituximab
Poland- Participants:0–17 years
- Substances:Rituximab
- Sponsor:Medical University Of Gdansk
Rare diseases
Investigational molecules
Locations
Back to Poland128 clinical trials in Zabrze, Poland across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on heart failure treatment and prevention, including studies of novel drug combinations like baxdrostat/dapagliflozin and sacubitril/valsartan. Research encompasses various cardiac conditions, from post-myocardial infarction care to atrial fibrillation management.
Multiple studies are examining innovative approaches to cardiac health management and prevention strategies.
Advanced clinical research in multiple sclerosis treatments, testing new therapies like frexalimab and ublituximab. Studies also include innovative approaches to treating Alzheimer's disease and chronic inflammatory demyelinating polyneuropathy.
Trials focus on improving patient outcomes and developing more effective treatment protocols.
Comprehensive studies addressing obesity management and diabetes control, particularly in adolescent populations. Research includes evaluation of new treatments like tirzepatide and innovative insulin therapies.
Research aims to develop more effective treatments for metabolic disorders across different age groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.